ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
2,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
3,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
4,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
5,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
5,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
6,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
7,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
8,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
9,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
10,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
11,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
12,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
13,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
13,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
17,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
17,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
17,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
17,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
18,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
19,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
20,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
20,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
20,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
20,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
21,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
22,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
22,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
24,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
24,2,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
25,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
26,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
26,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
28,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
28,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
30,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
31,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
32,2,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
32,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
33,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
34,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
34,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
35,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
35,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
35,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
36,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
36,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
36,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
36,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
37,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
38,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
39,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
40,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
40,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
40,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
42,1,Hypersensitivity vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
43,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
43,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
44,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
45,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
45,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
45,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
45,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
47,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
49,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
50,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
51,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
52,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
53,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
53,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
53,4,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
53,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
53,6,Normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
53,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
53,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
55,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
55,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
56,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
56,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
56,3,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
56,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
58,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
59,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
60,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
61,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
61,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
62,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,Y
63,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
63,2,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
63,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
65,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
66,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
67,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
67,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
67,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
68,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
68,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
69,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
70,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
70,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
71,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
71,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
72,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
74,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
74,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
76,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
76,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
77,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
78,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
79,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
79,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
79,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
79,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
80,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
81,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,Y
82,1,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
82,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
82,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
83,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
83,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
83,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
83,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
84,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
85,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
86,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
87,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
87,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
88,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
89,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
89,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
90,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
90,2,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
90,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
91,1,Headache,Headaches NEC,Headaches,Nerv,N
92,1,Albuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
92,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
92,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
92,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
93,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
94,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
94,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
95,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
96,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
97,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
97,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
97,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
98,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
99,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,3,Hypochromic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
99,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
99,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
99,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
99,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
101,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
102,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
103,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
104,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
105,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
106,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
107,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
108,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
108,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
109,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
110,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
111,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
112,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
113,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
114,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
114,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
114,3,Nephritis,Nephritis NEC,Nephropathies,Renal,N
115,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
117,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
118,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
118,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
118,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
118,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
119,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
121,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
121,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
122,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
123,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
124,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
124,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
126,1,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
127,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
127,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Prothrombin level decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
129,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
130,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
131,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
132,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
133,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
134,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,3,Haemorrhage urinary tract,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
135,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
135,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
135,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
135,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
136,1,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
137,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
137,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
139,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
139,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
139,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
139,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
140,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
141,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
142,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
144,1,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
144,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
144,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
144,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
144,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
145,1,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
146,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,2,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
147,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
148,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
149,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
149,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
149,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
149,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
149,5,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
150,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
150,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
150,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
151,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
153,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
154,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
154,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
156,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
157,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
158,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
158,2,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
158,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
158,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
159,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
159,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
159,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
159,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
159,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
159,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
159,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
160,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
161,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
161,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
162,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
163,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
164,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
164,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
165,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
166,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
166,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
167,1,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
167,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
167,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
167,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
167,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
167,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
169,1,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
170,1,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
